Long-Term Clinical Remission in Biologically Naïve Crohn's Disease Patients with Adalimumab Therapy, Including Analyses of Switch from Adalimumab to Infliximab.
about
Long-Term Clinical Remission in Biologically Naïve Crohn's Disease Patients with Adalimumab Therapy, Including Analyses of Switch from Adalimumab to Infliximab.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Long-Term Clinical Remission i ...... from Adalimumab to Infliximab.
@en
Long-Term Clinical Remission i ...... from Adalimumab to Infliximab.
@nl
type
label
Long-Term Clinical Remission i ...... from Adalimumab to Infliximab.
@en
Long-Term Clinical Remission i ...... from Adalimumab to Infliximab.
@nl
prefLabel
Long-Term Clinical Remission i ...... from Adalimumab to Infliximab.
@en
Long-Term Clinical Remission i ...... from Adalimumab to Infliximab.
@nl
P2093
P2860
P356
P1476
Long-Term Clinical Remission i ...... from Adalimumab to Infliximab
@en
P2093
Eiji Kubota
Hiromi Kataoka
Keiji Ozeki
Satoshi Tanida
Takahito Katano
Takashi Joh
Takeshi Kamiya
Tsutomu Mizoshita
Yoshinori Mori
P2860
P304
P356
10.1159/000445105
P577
2016-05-01T00:00:00Z